Literature DB >> 16769190

Value of diagnosis and differential diagnosis of MRI and MR spectroscopy in gliomatosis cerebri.

Aihong Yu1, Kuncheng Li, Hongli Li.   

Abstract

PURPOSE: The purpose of this study was to characterize gliomatosis cerebri on magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS), and to analyze the value of these two techniques in diagnosis and differential diagnosis of gliomatosis cerebri.
MATERIALS AND METHODS: MR images of 14 patients with gliomatosis cerebri were reviewed retrospectively; seven of the patients also underwent MRS (single-voxel point-resolved spectroscopy, and chemical-shift imaging point-resolved spectroscopy). Tumorous were confirmed by surgery and biopsy. The distribution, extension and signal features of lesions were assessed, and the MR spectroscopy results were analyzed.
RESULTS: Tumors involved at least two lobes of the brain in all patients. Widespread invasion with isointensity or hypointensity on T1-weighted MR images and hyperintensity on T2-weighted images were found while no prominent necrosis, hemorrhage or contrast enhancement was found. All patients who underwent MRS showed elevated Cho/Cr and Cho/NAA levels as well as decreased NAA/Cr ratios in the abnormal areas on T2-weighted images, three of which showed a lactate doublet. Anaplastic lesions had higher Cho/NAA levels in three cases. Abnormality of metabolism was also seen in the margin of the lesion that was normal on T2-weighted images.
CONCLUSION: MRI and MRS are valuable techniques for diagnosis and differential diagnosis of gliomatosis cerebri. Combining clinical information and MRI findings, as well as MRS, is crucial for making a definitive diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 16769190     DOI: 10.1016/j.ejrad.2006.03.001

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  8 in total

1.  Gliomatosis cerebri presenting as a recurrent cervical myelopathy.

Authors:  Marco A Lima; João C Campos; Bruno L Pessoa; Péricles Maranhão-Filho; Gabriela A Lima; Andreia S Barbosa; Hélio F Lopes
Journal:  J Neurol       Date:  2010-10-06       Impact factor: 4.849

Review 2.  Differential diagnosis of cerebral hemispheric pathology: multimodal approach.

Authors:  T Moritani; W R K Smoker; H K Lee; Y Sato
Journal:  Clin Neuroradiol       Date:  2011-04-29       Impact factor: 3.649

3.  Incidence and survival of gliomatosis cerebri: a population-based cancer registration study.

Authors:  Marios K Georgakis; Dimitrios Spinos; Apostolos Pourtsidis; Amanda Psyrri; Ioannis G Panourias; Spyridon Sgouros; Eleni Th Petridou
Journal:  J Neurooncol       Date:  2018-02-20       Impact factor: 4.130

4.  Gliomatosis cerebri: a review.

Authors:  Roberta Rudà; Luca Bertero; Marc Sanson
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

5.  Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI.

Authors:  Benjamin M Ellingson; Peter S LaViolette; Scott D Rand; Mark G Malkin; Jennifer M Connelly; Wade M Mueller; Robert W Prost; Kathleen M Schmainda
Journal:  Magn Reson Med       Date:  2010-11-30       Impact factor: 4.668

6.  Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data.

Authors:  Marios K Georgakis; Georgios Tsivgoulis; Dimitrios Spinos; Nikolaos G Dimitriou; Athanasios P Kyritsis; Ulrich Herrlinger; Eleni Th Petridou
Journal:  J Neurooncol       Date:  2018-08-16       Impact factor: 4.130

7.  Role of diffusion- and perfusion-weighted MR imaging for brain tumour characterisation.

Authors:  L Rizzo; S Greco Crasto; P Garcia Moruno; P Cassoni; R Rudà; R Boccaletti; M Brosio; R De Lucchi; C Fava
Journal:  Radiol Med       Date:  2009-05-06       Impact factor: 3.469

8.  Gliomatosis cerebri mimicking acute viral encephalitis and with malignant transformation of partial lesions: A case report.

Authors:  Peixin Sun; Haozhe Piao; Xu Guo; Zhengrong Wang; Rui Sui; Ye Zhang; Bing Yao; Yi Chen
Journal:  Exp Ther Med       Date:  2014-06-24       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.